• 10-for-1 reverse stock split: 10 existing shares with par value of €0.10 for 1 new share with par value of €1.00
  • Start date of the reverse stock split operation: February 27, 2019
  • Reverse stock split will become effective on March 29, 2019 (delisting of old shares and listing of new shares)


Genkyotex (Euronext Paris & Brussels: FR0011790542 – GKTX) a biopharmaceutical company and the leader in NOX therapies, today announced the launch of the reverse stock split, as approved by Genkyotex’ shareholders at the January 24, 2019 Extraordinary General Meeting.

This technical adjustment is purely arithmetical and has no impact on the value of Genkyotex shares held by the shareholders.